Perrigo closes Retin-A acquisition
Perrigo Co. plc has completed its acquisition of a portfolio of generic dosage forms and strengths of acne topical treatment Retin-A from Matawan Pharmaceuticals LLC. Financial terms of deal, announced in mid-December, weren’t disclosed.